Oak Thistle LLC acquired a brand new stake in Danaher Co. (NYSE:DHR – Free Report) within the 2nd quarter, in accordance with the corporate in its most up-to-date submitting with the SEC. The fund acquired 1,451 shares of the conglomerate’s inventory, valued at roughly $363,000.
A number of different hedge funds additionally just lately modified their holdings of the inventory. Patrick M Sweeney & Associates Inc. grew its place in Danaher by 3.4% through the second quarter. Patrick M Sweeney & Associates Inc. now owns 1,230 shares of the conglomerate’s inventory valued at $307,000 after buying an extra 40 shares over the past quarter. Belief Co of Kansas boosted its stake in shares of Danaher by 4.1% through the second quarter. Belief Co of Kansas now owns 1,022 shares of the conglomerate’s inventory valued at $255,000 after buying an extra 40 shares through the interval. Abacus Planning Group Inc. boosted its stake in shares of Danaher by 0.7% through the second quarter. Abacus Planning Group Inc. now owns 5,439 shares of the conglomerate’s inventory valued at $1,359,000 after buying an extra 40 shares through the interval. ST Germain D J Co. Inc. boosted its stake in shares of Danaher by 1.4% through the first quarter. ST Germain D J Co. Inc. now owns 2,880 shares of the conglomerate’s inventory valued at $719,000 after buying an extra 41 shares through the interval. Lastly, Premier Path Wealth Companions LLC boosted its stake in shares of Danaher by 1.8% through the second quarter. Premier Path Wealth Companions LLC now owns 2,345 shares of the conglomerate’s inventory valued at $586,000 after buying an extra 42 shares through the interval. Institutional traders personal 79.05% of the corporate’s inventory.
Analyst Upgrades and Downgrades
Plenty of analysts have just lately weighed in on the corporate. Financial institution of America elevated their value goal on Danaher from $270.00 to $275.00 and gave the corporate a “impartial” ranking in a analysis observe on Wednesday, July twenty fourth. TD Cowen elevated their value goal on Danaher from $290.00 to $310.00 and gave the corporate a “purchase” ranking in a analysis observe on Wednesday, July twenty fourth. Leerink Companions elevated their value goal on Danaher from $275.00 to $280.00 and gave the corporate an “outperform” ranking in a analysis observe on Wednesday, July twenty fourth. Evercore ISI dropped their value goal on Danaher from $266.00 to $260.00 and set an “outperform” ranking for the corporate in a analysis observe on Tuesday, July 2nd. Lastly, Barclays raised their value goal on Danaher from $270.00 to $285.00 and gave the inventory an “equal weight” ranking in a analysis observe on Wednesday, July twenty fourth. Seven analysts have rated the inventory with a maintain ranking and eleven have given a purchase ranking to the corporate’s inventory. In response to MarketBeat.com, the inventory presently has a consensus ranking of “Reasonable Purchase” and a median goal value of $278.94.
Examine Out Our Newest Report on DHR
Insider Shopping for and Promoting
In associated information, CFO Matthew Mcgrew offered 16,172 shares of Danaher inventory in a transaction dated Thursday, August 1st. The inventory was offered at a median value of $279.84, for a complete worth of $4,525,572.48. Following the completion of the sale, the chief monetary officer now instantly owns 29,407 shares within the firm, valued at roughly $8,229,254.88. The transaction was disclosed in a submitting with the Securities & Alternate Fee, which is offered via this hyperlink. In associated information, SVP Georgeann Couchara offered 952 shares of Danaher inventory in a transaction dated Monday, August twenty sixth. The inventory was offered at a median value of $268.37, for a complete worth of $255,488.24. Following the completion of the sale, the senior vp now instantly owns 4,212 shares within the firm, valued at roughly $1,130,374.44. The transaction was disclosed in a submitting with the Securities & Alternate Fee, which is offered via this hyperlink. Additionally, CFO Matthew Mcgrew offered 16,172 shares of Danaher inventory in a transaction dated Thursday, August 1st. The inventory was offered at a median value of $279.84, for a complete worth of $4,525,572.48. Following the completion of the sale, the chief monetary officer now owns 29,407 shares of the corporate’s inventory, valued at $8,229,254.88. The disclosure for this sale may be discovered right here. Within the final ninety days, insiders offered 39,659 shares of firm inventory value $11,042,433. 11.10% of the inventory is owned by company insiders.
Danaher Value Efficiency
Shares of NYSE:DHR opened at $273.09 on Tuesday. Danaher Co. has a 1-year low of $182.09 and a 1-year excessive of $281.70. The corporate has a debt-to-equity ratio of 0.33, a present ratio of 1.43 and a fast ratio of 1.04. The enterprise has a fifty day shifting common value of $261.87 and a 200-day shifting common value of $255.96. The corporate has a market capitalization of $197.23 billion, a PE ratio of 46.29, a PEG ratio of 4.38 and a beta of 0.83.
Danaher (NYSE:DHR – Get Free Report) final issued its quarterly earnings outcomes on Tuesday, July twenty third. The conglomerate reported $1.72 earnings per share for the quarter, beating the consensus estimate of $1.57 by $0.15. Danaher had a return on fairness of 11.06% and a internet margin of 16.94%. The agency had income of $5.74 billion through the quarter, in comparison with the consensus estimate of $5.59 billion. Throughout the identical interval final yr, the corporate earned $2.05 earnings per share. The corporate’s income was down 2.9% on a year-over-year foundation. As a bunch, equities analysts anticipate that Danaher Co. will publish 7.59 EPS for the present fiscal yr.
Danaher Firm Profile
Danaher Company designs, manufactures, and markets skilled, medical, industrial, and business services and products worldwide. The Biotechnology segments presents bioprocess applied sciences, consumables, and companies that advance, speed up, and combine the event and manufacture of therapeutics; cell line and cell tradition media improvement companies; cell tradition media, course of liquids and buffers for manufacturing, chromatography resins, filtration applied sciences, aseptic fill end; single-use {hardware} and consumables and companies, such because the design and set up of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical instruments; reagents, membranes, and companies; and healthcare filtration options.
Featured Articles
Need to see what different hedge funds are holding DHR? Go to HoldingsChannel.com to get the newest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Obtain Information & Rankings for Danaher Each day – Enter your e-mail handle under to obtain a concise each day abstract of the newest information and analysts’ scores for Danaher and associated firms with MarketBeat.com’s FREE each day e-mail e-newsletter.
